Prostate Cancer Complexity

The Mormons' religious beliefs have proven to be quite a boon for cancer epidemiologists. Members of the Church of Jesus Christ of Latter-day Saints, following religious tenets, have meticulously recorded their family trees for centuries. Recognizing the research value of such data, Mark Skolnick, chief scientific officer at Myriad Genetics Inc. in Salt Lake City, computerized those records at the church's family history library 25 years ago. Recently, researchers had high hopes that the data wo

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Those hopes have been whittled down. So far, comprehensive family histories haven't elucidated the cancer's hereditary underpinnings--the genetic component of prostate cancer continues to confound loci researchers. And, these researchers are not the only ones scratching their heads. Those studying genes involved in prostate cancer tumorigenesis have been able to find only a few tumor suppressor genes specific to prostate cancer, which was diagnosed in 170,000 men last year. "There are a lot of ideas about how to pursue prostate cancer," says William Foulkes, an assistant professor of medicine at McGill University. "But it's not obvious that there's any new technique out there that's going to solve the problems suddenly."

Unlike colon or breast cancer research, research into prostate cancer, which killed 31,000 men in 2000, hasn't yet uncovered genes that provide real prognostic value. Studies investigating tumorigenesis, for example, speak to the biology of the cancer itself; they are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Eugene Russo

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo